Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Oct 2010 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Nippon India Index Fund - BSE Sensex |
|---|---|
| 01 Oct 2010 | ₹100.00 |
| 28 Jan 2012 | ₹83.35 |
| 25 May 2013 | ₹96.51 |
| 21 Sep 2014 | ₹132.83 |
| 17 Jan 2016 | ₹120.05 |
| 15 May 2017 | ₹148.01 |
| 10 Sep 2018 | ₹186.47 |
| 07 Jan 2020 | ₹181.01 |
| 04 May 2021 | ₹196.18 |
| 31 Aug 2022 | ₹234.50 |
| 27 Dec 2023 | ₹285.16 |
| 24 Apr 2025 | ₹317.87 |
| 20 Aug 2026 | ₹312.67 |
| Metric | Nippon India · Regular · IDCW NAV ₹31.30 Very High risk ★★☆☆☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -4.78% | +4.72% | |
| +6.74% | +7.52% | |
| +6.72% | +8.28% | |
| +8.55% | +9.00% | |
| +7.44% | +7.27% | |
| +5.40% | — | |
| +10.24% | +7.88% | |
| +9.70% | +10.94% | |
| +9.62% | +9.63% | |
| Risk | ||
| 13.20% | 13.54% | |
| 0.02 | 0.11 | |
| 0.03 | 0.15 | |
| -44.42% | -15.67% | |
| Nifty 50 | — | |
| -1.08% | -0.05% | |
| 0.98 | 1.00 | |
| 97.7% | 101.3% | |
| 104.3% | 99.5% | |
| 0.51% | 0.88% | |
| ₹908.92Cr | ₹181.49Cr | |
| None | — | |
| None | — | |
| — | — | |
| ₹5.00K | — | |
| — | 38% | |
| Himanshu Mange | — | |
| 01 Oct 2010 | — | |
| — | — | |
| — | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.